2023 Q2 Form 10-Q Financial Statement

#000175337323000009 Filed on April 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $3.400K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $3.400K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $444.1K $31.39K
YoY Change 3377.48%
Operating Profit -$444.1K -$27.99K
YoY Change 3377.48%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$114.00
YoY Change
Pretax Income -$539.1K $27.99K $11.50K
YoY Change 4121.93% 143.38%
Income Tax
% Of Pretax Income
Net Earnings -$539.1K -$27.99K -$11.50K
YoY Change 4121.93% 143.38%
Net Earnings / Revenue -823.26%
Basic Earnings Per Share -$0.01 $0.00 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 7.105M shares 7.105M shares 5.092M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $308.2K $114.00 $114.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $13.57K
Receivables
Other Receivables
Total Short-Term Assets $308.2K $13.68K
YoY Change 1524.97%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $104.3K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $308.2K $13.68K
Total Long-Term Assets $0.00 $104.3K
Total Assets $308.2K $118.0K
YoY Change 1524.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.093K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $182.3K $142.3K
YoY Change 185.81%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $182.3K $142.3K
Total Long-Term Liabilities
Total Liabilities $182.3K $142.3K
YoY Change 185.81%
SHAREHOLDERS EQUITY
Retained Earnings -$690.9K $151.8K
YoY Change -946.8%
Common Stock $514.3K $7.105K
YoY Change 10000.82%
Preferred Stock
YoY Change
Treasury Stock (at cost) $435.0K
YoY Change
Treasury Stock Shares
Shareholders Equity $125.9K -$24.39K -$32.06K
YoY Change
Total Liabilities & Shareholders Equity $308.2K $118.0K
YoY Change 1524.97%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$539.1K -$27.99K -$11.50K
YoY Change 4121.93% 143.38%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$509.00 $1.619K
YoY Change -131.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $3.485K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.976K $1.619K
YoY Change 83.82%
NET CHANGE
Cash From Operating Activities -$509.00 $1.619K
Cash From Investing Activities $3.485K
Cash From Financing Activities $2.976K $1.619K
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$509.00 $1.619K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Interest Paid
InterestPaid
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001753373
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Proceeds From Customers
ProceedsFromCustomers
usd
CY2022Q1 us-gaap Revenues
Revenues
usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022Q1 us-gaap Development Costs
DevelopmentCosts
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-02-28
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-229748
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
INKY INC.
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
36 Aigyptou Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Larnaca
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
6030
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CY
CY2023Q1 dei City Area Code
CityAreaCode
357
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
25057246
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1904036
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7105357 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13567 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13767 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
13681 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13881 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
104272 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
111970 usd
CY2023Q1 us-gaap Assets
Assets
117953 usd
CY2022Q4 us-gaap Assets
Assets
125851 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1093 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
476 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
65500 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
49000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
75750 usd
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
72774 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
142343 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
122250 usd
CY2023Q1 us-gaap Liabilities
Liabilities
142343 usd
CY2022Q4 us-gaap Liabilities
Liabilities
122250 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7105357 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7105357 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
7105 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7105 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120255 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120255 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
151750 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
123759 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24390 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3601 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117953 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125851 usd
CY2023Q1 us-gaap Proceeds From Customers
ProceedsFromCustomers
3400 usd
CY2023Q1 us-gaap Revenues
Revenues
3400 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
3400 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31391 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11501 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
31391 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
11501 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27991 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11501 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
27991 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11501 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7105357 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5092023 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
5092023 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-20557 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-11501 usd
CY2022Q1 us-gaap Shares Outstanding
SharesOutstanding
5092023 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-32058 usd
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
7105357 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3601 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-27991 usd
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
7105357 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24390 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
27991 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
11501 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11183 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
200 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
325 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
16500 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
10500 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-617 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
943 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-509 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1619 usd
CY2023Q1 us-gaap Development Costs
DevelopmentCosts
3485 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3485 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2976 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1619 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2976 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1619 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zXy5XMz5ux9" style="font: 12pt/12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; background-color: white"><b><i><span id="xdx_864_z1ka0nE9VHF3">Use of Estimates</span></i></b></p> <p style="font: 12pt/12pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 24pt; background-color: white">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Cash
Cash
114 usd
CY2023Q1 us-gaap Shares Issued
SharesIssued
7105357 shares
CY2023Q1 us-gaap Advances Fair Value Disclosure
AdvancesFairValueDisclosure
2976 usd
CY2022Q4 us-gaap Advances Fair Value Disclosure
AdvancesFairValueDisclosure
1619 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
8000 usd
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
8000 usd
CY2023Q1 inki Database
Database
5300 usd
CY2022 inki Database
Database
5300 usd
CY2023Q1 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
267 usd
CY2022 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
467 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13567 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13767 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
4055 usd

Files In Submission

Name View Source Status
0001753373-23-000009-index-headers.html Edgar Link pending
0001753373-23-000009-index.html Edgar Link pending
0001753373-23-000009.txt Edgar Link pending
0001753373-23-000009-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inki-20230228.xsd Edgar Link pending
inky10q_feb23.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
inki-20230228_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
inki-20230228_def.xml Edgar Link unprocessable
inki-20230228_lab.xml Edgar Link unprocessable
inki-20230228_pre.xml Edgar Link unprocessable
inky10q_feb23_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending